{"id":"NCT02294019","sponsor":"Pfizer","briefTitle":"Actual Use Trial of Ibuprofen 400 mg","officialTitle":"A Multicenter Actual Use And Compliance Study Of Ibuprofen 400 Mg In A Simulated Over-the-counter Environment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11","primaryCompletion":"2015-05","completion":"2015-05","firstPosted":"2014-11-19","resultsPosted":"2016-05-30","lastUpdate":"2016-05-30"},"enrollment":738,"design":{"allocation":null,"model":null,"masking":"NONE","primaryPurpose":null},"conditions":["Patient Compliance"],"interventions":[{"type":"DRUG","name":"Ibuprofen 400 mg caplet","otherNames":[]}],"arms":[{"label":"Ibuprofen caplet arm","type":"EXPERIMENTAL"}],"summary":"This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.","primaryOutcome":{"measure":"Percentage of Participants Taking Greater Than (>) 1200 Milligram (mg) (>3 Caplets) on no More Than 2 Use Days During the Study","timeFrame":"Day 1 up to 30 days","effectByArm":[{"arm":"Ibuprofen","deltaMin":95.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":25,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B3491013&StudyName=A%20Multicenter%20Actual%20Use%20And%20Compliance%20Study%20Of%0Aibuprofen%20400%20Mg%20In%20A%20Simulated%20Over-the-counter%20Environment"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":736},"commonTop":["Nasopharyngitis","Gastrooesophageal reflux disease","Dizziness","Constipation","Nausea"]}}